MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- RASOYA PROTEINS
RASOYA PROTEINS Share Price (RSYP)
Here is the latest stock price and chart of RASOYA PROTEINS. For more details, see the RASOYA PROTEINS company fact sheet and quarterly results.
Free Guide: Find the Next Crorepati Stock in this Futuristic Industry
| Live BSE Quotes | Nov 5, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)0.16 | Open (Rs) 0.16 | High (Rs) 0.16 | Low (Rs) 0.16 |
| % Change0.00 | Volume 10 | Value (Rs) 1 | 52-Week H/L 0.16 / 0.16 |
| Live NSE Quotes | Feb 5, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)0.05 | Open (Rs) 0.05 | High (Rs) 0.05 | Low (Rs) 0.05 |
| % Change0.00 | Volume 482,470 | Value (Rs) 24,124 | 52-Week H/L 0.25 / 0.05 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 0.06 | P/E Ratio (x) 2.58 | Market Cap (Rs m) 273.43 | P/BV (x) 0.58 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
|
| |
Today's Market
Sensex Opens Flat; Sun Pharma and ITC Top Losers(09:30 am)
Asian stock markets are mixed today. The Nikkei 225 is flat while the Hang Seng is down 0.3%. The Shanghai Composite is trading up by 0.1%.
Related Views On News
Galaxy Surfactants Ltd. (IPO)
Jan 27, 2018Should you subscribe to the IPO of Galaxy Surfactants Ltd?
More Views on NewsMost Popular
Use My Secret to Increase Your Trading Profits Today
Dec 10, 2019What to do after every trade.
How We Made 14.64% Trading Profit in Just 2 Days
Dec 12, 2019A high probability trade that worked to perfection for my subscribers.
Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)
Dec 5, 2019This corner of the market could provide more returns than blue chips in 2020.
Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)
Dec 3, 2019Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.
Stocks that Can Outperform No Matter what the RBI Does Today (The 5 Minute Wrapup)
Dec 5, 2019I won't be surprised if these stocks repeat their 2002-2006 performance.
MoreTRACK RASOYA PROTEINS
- Track your investment in RASOYA PROTEINS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON RASOYA PROTEINS
RASOYA PROTEINS - GOODRICKE COMPARISON
COMPARE RASOYA PROTEINS WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.